Gestational diabetes is a common pregnancy complication that requires special attention to preserve the health of both the mother and the child. Today, screening for gestational diabetes is mainly performed on women with specific risk factors, using a test called OGTT. This test detects possible glucose intolerance in order to adapt management. This article details the screening process, recommendations, and precautions to ensure optimal pregnancy monitoring.
🕒 Article summary
Understanding the gestational diabetes test and knowing for whom it is essential is key to better experiencing pregnancy and minimizing risks.
- ✅ Targeted screening choice: The OGTT reserved for women with specific risk factors
- ✅ Precise test procedure: Fasting blood samples, then after glucose ingestion
- ✅ Clear diagnostic thresholds: Fasting and post-glucose blood sugar for confirmation
- ✅ Important precautions: The duration and tolerance of the test explained in detail
📌 Targeted and informed screening allows anticipation to better protect mom and baby.
- Contents:
- 1. Why is gestational diabetes no longer systematically screened?
- 2. Who absolutely must take the OGTT?
- 3. How is the OGTT conducted in the laboratory?
- 4. Interpretation of results and diagnostic thresholds
- 5. Practical advice and precautions around the screening test
- FAQ: Frequently asked questions about gestational diabetes screening
Why is gestational diabetes no longer systematically screened?
Gestational diabetes is defined by the World Health Organization (WHO) as a disorder that first occurs during pregnancy, causing an excessive rise in blood glucose levels. At the end of pregnancy, this hyperglycemia can lead to complications for the mother such as gestational hypertension, preeclampsia, or premature delivery, but also for the baby, notably fetal macrosomia (“large” baby) and risks of neonatal hypoglycemia.
Historically, screening was offered to all pregnant women through a systematic test. However, research conducted over the past decade has enabled the targeting of higher-risk populations. In 2010, recommendations evolved significantly: now, the OGTT (Oral Glucose Tolerance Test) is reserved only for women with certain risk factors.
This shift aims to reduce the number of unnecessary tests, limit the stress and constraints linked to systematic screening while improving the relevance of management. As a reminder, the simple search for sugar in urine, systematically done during consultations, does not allow a reliable diagnosis of gestational diabetes but detects suspicion that must be confirmed by other tests.
This targeted approach is supported by several recent studies published by Roche Diagnostics and Sanofi, which demonstrate that restricted screening to at-risk women optimizes resources while maintaining effective management. Collaboration among laboratories, such as Abbott with its digital analytical solutions, and health professionals now facilitates a finer and personalized detection of this pathology during pregnancy.
Advantages of targeted screening rather than systematic screening
- 🎯 Focusing medical resources on at-risk patients increases effectiveness
- ⏱ Reduces time spent in the laboratory for low-risk women
- 💡 Decreases stress and complications related to unnecessary screening
- 🔬 Allows more personalized monitoring with modern glycemia measurement tools, such as Freestyle Libre or Accu-Chek
At the heart of this strategy, healthcare professionals, including gynecologists, midwives, and diabetes specialists, will adapt this screening for each pregnancy while maintaining the necessary vigilance to protect mother and child.
Who absolutely must take the OGTT?
The OGTT is recommended only for pregnant women presenting identified risk factors considered significant for developing gestational diabetes. This true “selection” concerns several profiles clearly defined by health authorities and confirmed by field data collected by organizations like Bayer Diabetes Care or Novo Nordisk:
- 👩🦳 Pregnant women over 35 years old
- ⚖️ Women with a Body Mass Index (BMI) ≥ 25, covering overweight and obesity
- 🩺 Personal history of gestational diabetes during a previous pregnancy
- 👨👩👧 First-degree family members (parents, siblings) with known diabetes
- 👶 Having already given birth to a baby weighing over 4 kg (macrosomia)
It is important to note that only one criterion is sufficient for the woman to be invited to undergo the test. The warning is all the stronger because vigilance must be maximal, especially since undiagnosed gestational diabetes can have serious repercussions on the course of the pregnancy.
To better understand these recommendations and their rationale, it may be useful to consult a guide on the early signs of diabetes. This guide describes the importance of adapted screening to reduce medium- and long-term complications.
The key role of healthcare professionals
The gynecologist or midwife directs the pregnant woman to take the OGTT. This recommendation is not mandatory: the patient has the right to accept or decline, after being informed of the potential risks in case of no screening.
- 🗣 Clear information about possible consequences: gestational hypertension, preeclampsia
- 🍼 Reminder of risks for the baby: macrosomia, birth complications, hypoglycemia
- 🤝 Support for the decision: listening and assistance during the process
How is the OGTT conducted in the laboratory?
The OGTT, or oral glucose tolerance test, is a simple but rigorous exam that requires prior preparation and precise monitoring to be reliable. Organized over a session lasting about 2 to 2.5 hours, it is performed in a medical analysis laboratory or a specialized facility.
- ⏰ Arrive fasting, with a strict fast of 8 to 12 hours beforehand. Drinking a little water is allowed, but moderation is advised so as not to affect blood glucose concentration.
- 💉 A first blood sample is taken fasting to measure baseline blood glucose.
- 🥤 The patient then drinks 75 g of pure glucose diluted in approximately 200 ml of water, in less than ten minutes. Flavors like lemon or cola are sometimes offered to facilitate intake.
- ⏳ Two additional blood draws are performed: one at 1 hour, then another at 2 hours after glucose consumption.
- 🪑 The patient remains seated throughout the test duration to avoid any energy expenditure that could skew the results.
The particularly sugary drink may cause side effects: fatigue, nausea, sometimes even vomiting. It is advised to drink it in one go to minimize discomfort. In case of vomiting, the test must be redone another day as the results would be invalid.
This test proves difficult for some patients, notably those who have undergone bariatric surgery such as gastric bypass or sleeve gastrectomy, for whom it is contraindicated due to the risk of dumping syndrome. These women then benefit from other forms of glycemia control, such as fasting and postprandial blood glucose measurement, which are less invasive but validated.
How does this test differ from classical monitoring with modern tools?
Thanks to technological advances, blood glucose monitoring in pregnant women now takes into account continuous or semi-continuous measurement tools, offered by diabetes market players such as Contour, GlucoMen, and OneTouch. This allows for more personalized and adapted control, but the OGTT remains an essential step to confirm or exclude gestational diabetes.
Interpretation of results and diagnostic thresholds of gestational diabetes
OGTT results are usually available within 12 to 48 hours after sampling, depending on the laboratories. The diagnosis of gestational diabetes will be confirmed as soon as the patient exceeds one of the following glycemic thresholds:
| Time of measurement 🕒 | Glycemic threshold not to exceed 💉 |
|---|---|
| Fasting | 0.92 g/L (5.1 mmol/L) |
| 1 hour after ingestion | 1.80 g/L (10 mmol/L) |
| 2 hours after ingestion | 1.53 g/L (8.5 mmol/L) |
It is important to note that a single elevated value is enough to make the diagnosis, which highlights the importance of rigorous control and adapted management. Moreover, in some cases, the OGTT may reveal a more constant glucose intolerance, corresponding to previously undiagnosed type 2 diabetes. Such situations then require specific medical support.
Data collected by Bayer Diabetes Care and Roche Diagnostics allow improved monitoring of these patients, thanks to adapted protocols and strengthened communication between specialists.
What are the consequences after a positive diagnosis?
- 🩺 Implementation of specific glycemic monitoring, sometimes with the help of adapted devices
- 🍏 Adaptation of diet and personalized nutritional advice
- 🏃 Recommendation of moderate but regular physical activity
- ⚠️ Close pregnancy monitoring to prevent complications
Practical advice and precautions around the gestational diabetes screening test
The OGTT requires some preparation to be well tolerated and effective. As mentioned above, it is advised to arrive having respected the fast, and to bring something to occupy oneself during the waiting time (book, music via smartphone, small snacks to consume after the test). These 2 to 2.5 hours may seem long, but this patience is essential to obtain reliable results and ensure proper pregnancy monitoring.
Practical tips:
- 🎧 Bring headphones and a favorite playlist to relax
- 📱 Ensure the phone is charged for the duration of the test
- 🧊 Drink the sugary solution in one go to avoid nausea
- 👩⚕️ Come accompanied by a loved one if necessary for moral support
If nausea appears during the test, it is best to inform the healthcare staff. In case of vomiting, unfortunately a new date will have to be scheduled, which can delay diagnosis. Women who have undergone bariatric surgery should report this as an alternative method will be offered.
Finally, it is possible to schedule this test on a day off or in the morning, in a laboratory that opens early, thus facilitating professional sessions with minimal disruption.
Manufacturer roles and innovations in gestational diabetes monitoring
Brands such as Accu-Chek, OneTouch, Freestyle Libre, Contour, GlucoMen, in collaboration with Roche Diagnostics, Abbott, Bayer Diabetes Care, Sanofi, and Novo Nordisk, constantly innovate to offer more comfortable and precise glycemic monitoring devices. These tools contribute to personalized follow-up after screening, complementing traditional medical practices.
Test your knowledge about gestational diabetes
Gestational diabetes screening fits into a dynamic of prevention and personalized support. Thanks to technological advances and a better understanding of risk factors, pregnant women now benefit from better targeted monitoring, which helps limit many complications.
Is the OGTT painful?
The test consists of repeated blood draws, which may cause brief discomfort but is not painful in the strict sense. The ingestion of glucose syrup can cause nausea in some patients.
Can I drink water before the OGTT?
It is possible to drink a small amount of water before the test, but it is recommended to avoid drinking too much to not dilute glucose concentration in the blood.
What is the risk of not taking the test if a woman is at risk?
Not screening for gestational diabetes can lead to serious complications such as gestational hypertension, preeclampsia, a large baby, or cesarean delivery.
Can the OGTT be done after bariatric surgery?
The OGTT is not recommended in cases of bypass or sleeve gastrectomy because of the risk of dumping syndrome. An alternative measurement of fasting and postprandial blood glucose is then proposed.
